Good practice is NOT needed in which phase of clinical trial:
**Core Concept**
Good practice, as defined by the International Conference on Harmonisation (ICH) E6 (R2), refers to the guidelines and standards for the conduct of clinical trials. It ensures that clinical trials are conducted with high-quality data, adequate safety measures, and respect for human subjects. Good practice is a critical component of clinical trial design and execution.
**Why the Correct Answer is Right**
The correct answer is related to **Phase 0 clinical trials**, which are exploratory, first-in-human studies that aim to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of a new investigational product. Since Phase 0 trials are small-scale, first-time studies, the emphasis is on safety and feasibility rather than efficacy. Therefore, Good Practice Guidelines (GCP) are not strictly applicable to Phase 0 trials, and the focus is on obtaining preliminary data on the product's safety profile.
**Why Each Wrong Option is Incorrect**
**Option A:** This option might seem plausible, but Good Practice is essential in all phases of clinical trials, including Phase 1, to ensure high-quality data and subject safety.
**Option B:** This option is incorrect because Good Practice is still necessary in Phase 2 trials, which evaluate the efficacy and safety of a product in a larger population.
**Option C:** This option is also incorrect because Good Practice is essential in Phase 3 trials, which assess the efficacy and safety of a product in a large population before marketing approval.
**Clinical Pearl / High-Yield Fact**
Remember that Good Practice Guidelines (GCP) are not applicable to Phase 0 clinical trials, which are exploratory, first-in-human studies that focus on safety and feasibility.
**Correct Answer: A. Good Practice is NOT needed in Phase 0 clinical trials.**